EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

Antifibrotic Drugs Regulate the Expression of Epithelial Sodium Channels in the Lungs

Toshiyuki Ito, Hajime Fujimoto iD, Masaaki Toda, Valeria Fridman D'Alessandro, Corina N D'Alessandro-Gabazza iD, Yurie Kogue, Tatsuki Tsuruga, Tomohito Okano, Kazuki Furuhashi, Haruko Saiki, Atsushi Tomaru, Esteban C Gabazza iD und 2 weitere

Advances in Respiratory Medicine · 29.04.2026 · 94 (3) · 30

DOI: 10.3390/arm94030030 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Advances in Respiratory Medicine, online erschienen am 29.04.2026. Verfasst von Toshiyuki Ito und 13 weiteren Autor:innen. Beteiligte Einrichtung: Department of Pulmonary and Critical Care Medicine, Faculty and Graduate School of Medicine, Mie University, Edobashi 2-174, Tsu 514-8507, Mie, Japan. Hauptthemen laut MEDLINE: Epithelial Sodium Channels, Indoles, Pyridones, Antifibrotic Agents. Die Arbeit nennt 56 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Japan Society for the Promotion of Science, Shionogi (Japan), MSD Life Science Foundation.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Purpose

A high-salt extracellular environment promotes fibrosis in multiple organs by inducing oxidative stress, fibroblast activation, and extracellular matrix remodeling. In the lung, sodium accumulation may result from impaired epithelial ion transport. Transforming growth factor-β1 (TGF-β1), a key profibrotic cytokine, downregulates epithelial sodium and chloride channels, promoting sodium retention and fibrotic remodeling. This study investigated whether antifibrotic drugs can prevent TGF-β1-induced suppression of sodium channel expression in the lung epithelium.

Methods

Human A549 alveolar epithelial cells and primary alveolar epithelial cells were cultured with or without TGF-β1 in the presence or absence of nintedanib or pirfenidone. Expression of epithelial sodium channel (ENaC) subunits (SCNN1A, SCNN1B, SCNN1G, SCNN1D) and CFTR was analyzed. In vivo, lung tissues from TGF-β1 transgenic mice and wild-type controls were examined following intranasal administration of pirfenidone.

Results

TGF-β1 markedly reduced the expression of all ENaC subunits and CFTR in vitro. Nintedanib prevented suppression of SCNN1A, SCNN1D, and SCNN1G, whereas pirfenidone prevented suppression of SCNN1A, SCNN1B, and SCNN1G. In TGF-β1 transgenic mice, Scnn1a, Scnn1b, and Scnn1g expression was significantly decreased compared with wild-type controls. Pirfenidone administration dose-dependently restored expression of these ENaC subunits in vivo.

Conclusions

Antifibrotic drugs partially prevent TGF-β1-induced suppression of epithelial sodium channels, preserving epithelial ion homeostasis. Restoration of ENaC expression may represent a novel mechanism by which antifibrotic therapy mitigates sodium-associated lung fibrosis.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Epithelial Sodium ChannelsIndolesPyridonesAntifibrotic AgentsPulmonary FibrosisLungAnimalsHumansTransforming Growth Factor beta1MiceMice, TransgenicCystic Fibrosis Transmembrane Conductance Regulator

Stichwörter der Autor:innen

TGF-β1epithelial sodium channelsnintedanibpirfenidonepulmonary fibrosis

Substanzen

Epithelial Sodium ChannelsIndolespirfenidoneTransforming Growth Factor beta1PyridonesAntifibrotic AgentsnintedanibCystic Fibrosis Transmembrane Conductance Regulator

Autor:innen und Institutionen

  • Department of Pulmonary and Critical Care Medicine, Faculty and Graduate School of Medicine, Mie University, Edobashi 2-174, Tsu 514-8507, Mie, Japan.
  • Department of Immunology, Faculty and Graduate School of Medicine, Mie University, Edobashi 2-174, Tsu 514-8507, Mie, Japan.
  • Microbiome Research Center, Mie University, Edobashi 2-174, Tsu 514-8507, Mie, Japan.

ORCID-Profile: Hajime Fujimoto, Corina N D'Alessandro-Gabazza, Esteban C Gabazza

Förderung

  • Japan Society for the Promotion of Science
  • Shionogi (Japan)
  • MSD Life Science Foundation
  • Terumo (Japan)

Zitieren

APA

Ito, T., Fujimoto, H., Toda, M., Fridman D'Alessandro, V., D'Alessandro-Gabazza, C. N., Kogue, Y., Tsuruga, T., Okano, T., Furuhashi, K., Saiki, H., Tomaru, A., Gabazza, E. C., Yasuma, T., & Kobayashi, T. (2026). Antifibrotic Drugs Regulate the Expression of Epithelial Sodium Channels in the Lungs. Advances in Respiratory Medicine, 94(3), 30. https://doi.org/10.3390/arm94030030

Vancouver

Ito T, Fujimoto H, Toda M, Fridman D'Alessandro V, D'Alessandro-Gabazza CN, Kogue Y, et al. Antifibrotic Drugs Regulate the Expression of Epithelial Sodium Channels in the Lungs. Advances in Respiratory Medicine. 2026;94(3):30. doi:10.3390/arm94030030

BibTeX
@article{Ito2026,
  author = {Ito, Toshiyuki and Fujimoto, Hajime and Toda, Masaaki and Fridman D'Alessandro, Valeria and D'Alessandro-Gabazza, Corina N and Kogue, Yurie and Tsuruga, Tatsuki and Okano, Tomohito and Furuhashi, Kazuki and Saiki, Haruko and Tomaru, Atsushi and Gabazza, Esteban C and Yasuma, Taro and Kobayashi, Tetsu},
  title = {Antifibrotic Drugs Regulate the Expression of Epithelial Sodium Channels in the Lungs},
  journal = {Advances in Respiratory Medicine},
  year = {2026},
  volume = {94},
  number = {3},
  pages = {30},
  doi = {10.3390/arm94030030}
}
Kostenlos starten →